Top News

Label or Liability: Case law could lead to short shelf life for $3M Paxil 'innovator liability' verdict

Stephanie N. Grimoldby Jun. 13, 2017, 11:00am

A Chicago federal jury shocked many observers by ordering drugmaker GlaxoSmithKline to pay $3 million to the widow of lawyer Stewart Dolin, who committed suicide in 2010 after taking a generic version of GSK's antidepressant Paxil. But legal observers believe the decision may have a short shelf life, as it could defy decades of case law on the concept of innovator liability.

GSK asks for new trial over claims its anti-depressant labeling contributed to lawyer's suicide

Dan Churney May 31, 2017, 11:18am

Drug manufacturer GlaxoSmithKline is trying to get out from under a $3 million jury judgment, which blamed it for a Chicago lawyer’s suicide, saying a federal judge made multiple mistakes that hamstrung the manufacturer’s defense against the claim its labels failed to warn its anti-depressant drug Paxil and its generic equivalent can lead to suicide.

Federal judge tosses some accusations vs testosterone drug makers on eve of Androgel bellwether trials

Dan Churney May 16, 2017, 3:34pm

A Chicago federal judge has dismissed several. but not all of the claims against the maker of a testosterone boosting drug, advanced by several plaintiffs chosen as bellwethers in a class-action lawsuit brought by more than 2,000 plaintiffs from around the U.S. against multiple drug manufacturers, including Besins, AbbVie, Eli Lilly and GlaxoSmithKline.

Jury: GSK liable for suicide of lawyer taking generic Paxil; $3M awarded to widow

Jonathan Bilyk Apr. 20, 2017, 4:04pm

A federal jury in Chicago has ordered pharmaceutical maker GlaxoSmithKline to pay $3 million to the widow of a Chicago lawyer who committed suicide by jumping in front of a train after taking a generic version of Paxil, an antidepressant developed by GSK, finding the drugmaker should be held responsible for his death, even though it didn’t make the actual medication the lawyer had been taking for about a week before he took his life.

Drug makers' testosterone replacement drug injured Georgia resident, suit claims

Louie Torres Apr. 10, 2017, 12:53pm

A Georgia man is suing several drug makers, including GlaxoSmithKline and Auxilium, for alleged design defect, liability and negligence for injuries he suffered while taking testosterone drugs.

Judge denies request to end trial vs drugmaker GSK over suicide of lawyer taking generic Paxil

Jonathan Bilyk Apr. 6, 2017, 4:41pm

A trial continues this week in Chicago federal court over the question of how much blame should be shouldered by drugmaker GlaxoSmithKline for the death of a Chicago lawyer who committed suicide after taking a generic version of Paxil, an antidepressant developed by GSK. This week, a federal judge denied an attempt by GSK to abruptly end the weeks-long trial and secure a judgment in its favor.

Trial set to begin in litigation vs drugmaker GSK over suicide by lawyer who took generic Paxil

Jonathan Bilyk Mar. 13, 2017, 8:03pm

This week, a Chicago federal court will empanel jurors to decide whether pharmaceutical maker GlaxoSmithKline should be made to pay the widow of a Chicago lawyer who committed suicide by jumping in front of a train after taking a generic version of Paxil, an antidepressant developed by GSK, because, the woman claims, the drug’s warning label, which was approved by federal regulators, did not contain enough information on suicide risk, misleading the doctor who prescribed it.

GlaxoSmithKline must face Paxil birth defects claims from out-of-state plaintiffs in Cook County: Panel

Jonathan Bilyk Aug. 29, 2016, 3:33pm

Drugmaker GlaxoSmithKline, a United Kingdom-based company whose U.S. operations are headquartered in Philadelphia, will need to face legal action in Cook County court over claims its drug, Paxil, caused birth defects, after an appeals court ruled local state courts have jurisdiction under Illinois law to preside over the lawsuits – even complaints brought by plaintiffs who have no significant connection to Illinois.

Judge tosses insurers' RICO class action vs testosterone drug makers, saying not specific enough

Jonathan Bilyk Feb. 4, 2016, 5:38pm

A federal judge has tossed, with leave to amend, the bulk of a federal racketeering and fraud class action brought by an Ohio-based health insurer against Abbvie and other makers of testosterone drugs, saying the insurer has not yet backed up with enough particularity its allegations the drugmakers invented the condition known as “low T,” and, through false marketing to doctors, patients and insurers alike, induced insurers and others to pay far more for the drugs to treat the condition.